Literature DB >> 29685816

The complement story in Guillain-Barré syndrome: from pathogenesis to therapy.

Eduardo Nobile-Orazio1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29685816     DOI： 10.1016/S1474-4422(18)30144-3

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  5 in total

1.  Surgery and Guillain-Barré Syndrome: A Single-Center Retrospective Study Focused on Clinical and Electrophysiological Subtypes.

Authors:  Lei Bao; Xueting Chen; Qingjie Li; Ruixue Zhang; Hongjuan Shi; Guiyun Cui
Journal:  Neuropsychiatr Dis Treat       Date:  2020-04-15       Impact factor: 2.570

2.  An incomplete form of anti-ganglioside antibody-positive Miller Fisher syndrome after an Epstein-Barr virus infection: A case report.

Authors:  Le Chang; Jing Xiong; Yuying Xue; Jie Wang; Xurong Zhu; Xuejiao Zheng; Xiaoyu Gao; YuE Yan; Jiaduo Hao; Hehuan Zhao; Zhengli Di
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

Review 3.  Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.

Authors:  Luis Querol; Cinta Lleixà
Journal:  Neurotherapeutics       Date:  2021-09-21       Impact factor: 7.620

4.  Post-adenoviral-based vaccines Guillain-Barre Syndrome: A proposed mechanism.

Authors:  Kamran Kadkhoda
Journal:  Med Hypotheses       Date:  2022-02-12       Impact factor: 1.538

5.  Miller Fisher Variant of Guillain-Barré Syndrome Triggered by Ventilator-Associated Pneumonia.

Authors:  Danah Aljaafari; Salam Almustafa; Abdulrahman Saleh Ali; Hosam Aldalbahi; Norah Ibrahim Albahli; Feras AlSulaiman; Anas Al Dehailan; Majed Alabdali
Journal:  Int Med Case Rep J       Date:  2021-05-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.